Hackernews posts about Pharma CIO
- Pharma-Marketing.com: The New Pharma Marketing Magazine (www.pharma-marketing.com)
- Health insurance execs shift blame for costly, confusing health care system (www.statnews.com)
- PlaceboBench: An LLM hallucination benchmark for pharma (www.blueguardrails.com)
- Asha Sharma Named EVP and CEO, Microsoft Gaming (blogs.microsoft.com)
- Xbox chief Phil Spencer retiring after 38 years at Microsoft (www.geekwire.com)
- Show HN: Bhagavan – a calm, approachable app for exploring Hinduism (www.bhagavan.io)
- Mrinank Sharma Resigns from Anthropic (twitter.com)
- Show HN: Claude has a compiler, I have SlopScript (slopscript.netlify.app)
- IsoCity: City Building Simulation Game (github.com)
- A CIO canceled a Microsoft AI deal (www.businessinsider.com)
- Econ 101 Is Underrated: Pharma Price Controls (marginalrevolution.com)
- Russia is getting Nvidia AI chips from an Indian pharma company (timesofindia.indiatimes.com)
- Genetic Engineering of Plants Can Solve Pharma's Cost Crisis (www.greyb.com)
- Show HN: An open-source implementation of AlphaFold3 (github.com)
- Show HN: We Identified a Counterfeit Pharmaceutical Product in Uzbekistan (yashsm01-glwdj.wordpress.com)
- Supreme Court blocks controversial Purdue Pharma opioid settlement (www.washingtonpost.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Amid restructuring, Novo Nordisk directs employees to return to office (www.fiercepharma.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose (www.fiercepharma.com)
- Pharma Giants, Crypto Profits: How Ozempic Could Redefine Corporate Investment (ion-oaie.medium.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Moderna's mRNA vaccine manufacturing operations reveal state of the company (www.fiercepharma.com)
- J&J subsidiary floats $6.48B settlement to resolve claims products caused cancer (www.fiercepharma.com)
- Stealth scores FDA approval for first Barth syndrome treatment (www.fiercepharma.com)
- The Drug Industry Is Having Its Own DeepSeek Moment (www.wsj.com)